WASHINGTON, Oct. 27, 2021 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the third quarter 2021 on Wednesday, November 3, 2021, after the market
closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, November 3, 2021, during which
management will discuss the third quarter 2021 financial results
and other corporate activities. To participate in the conference
call, please dial 1-866-688-9426 (domestic) or 1-409-216-0816
(international) and use passcode 5961858.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Wednesday, November 3, 2021, beginning at
7:30 PM ET and will be accessible
until Wednesday, November 10, 2021,
at 7:30 PM ET. The replay call-in
number is 1-855-859-2056 for domestic callers and 1-404-537-3406
for international callers. The passcode number is 5961858.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2021-financial-results-on-november-3-2021-301410363.html
SOURCE Vanda Pharmaceuticals Inc.